John Stefancin, MD
Orthopaedic Surgery · Youngstown, OHNPI 1770772147
Payments from drug & device makers
Across 133 payments — averaging $76.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mid-atlantic Surgical Systems, LLC$4K
- Arthrex$2K
- Stryker$2K
- Zimmer Biomet$760
- Medtronic$207
- EBI, LLC$195
- plus $847 from 16 others
What the payments were for
- Travel & lodging$4,35643%
- Food & beverage$3,97239%
- Education$1,81718%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mid-atlantic Surgical Systems, LLC | 12 | $3,742 |
| Arthrex | 51 | $2,460 |
| Stryker | 18 | $1,934 |
| Zimmer Biomet | 9 | $760 |
| Medtronic(2 entities) | 8 | $207 |
| EBI, LLC | 1 | $195 |
| Johnson & Johnson(2 entities) | 9 | $192 |
| Miach Orthopaedics, Inc. | 1 | $148 |
| Si-bone, Inc. | 1 | $101 |
| Ferring Pharmaceuticals Inc. | 5 | $60 |
| Bioventus LLC | 3 | $58 |
| Pacira Pharmaceuticals Incorporated | 2 | $43 |
| Pacira Therapeutics, Inc. | 2 | $39 |
| DJO, LLC | 2 | $39 |
| Zyla Life Sciences, Inc. | 2 | $32 |
| Arthrosurface Incorporated | 1 | $28 |
| Ultragenyx Pharmaceutical Inc. | 1 | $25 |
| Heron Therapeutics, Inc. | 1 | $21 |
| Smith+Nephew | 1 | $18 |
| Vertex | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Anika Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,144 in reported general payments places this provider in the 70th percentile of 794 orthopaedic surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 26 | $283 |
| Methylprednisolone | 36 | $178 |
| Tramadol Hcl | 61 | $148 |
| Oxycodone Hcl | 14 | $138 |
| Cyclobenzaprine Hcl | 15 | $121 |
| Gabapentin | 19 | $96 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $67 |
| Cephalexin | 11 | $66 |
| Meloxicam | 23 | $55 |
| Amoxicillin | 42 | $49 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Youngstown
- John SontichYoungstown$3.6M
- Reuben GobezieCleveland$12.6M
- Brad PichaIndependence$12.3M
- Gregory BerletWorthington$9.9M
- Wael BarsoumCleveland$8.9M
- Brian CohenChillicothe$8.9M
- Joseph IannottiCleveland$7.1M
- Anthony MiniaciCleveland$3.1M
- Mark FroimsonCleveland$2.9M
- David WelkerMiamisburg$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.